HEALTH● LOW2h ago · Sep 30, 2026, 1:28 PM
Merck succeeds in mid-stage trial for skin disease drug
Seeking Alpha Tech · global
Merck has successfully completed a mid-stage trial for a new drug designed to treat skin disease, which could lead to new treatment options for patients.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoSlashing sugar intake before antibiotics may save your microbiomeNew ScientistHEALTH1h agoI couldn’t walk — Adekunle Gold recounts sickle cell crisis on flight to TanzaniaVanguard NigeriaHEALTH1h ago‘Astonishing’ weight loss when GLP-1 drug used with second medicationNew ScientistHEALTH2h agoClear ₹2,500 crore hospital dues, Telangana network hospital body urges govt.The Hindu